Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background

Clomipramine, a Tricyclic Antidepressant (TCA), is known for its efficacy in treating Obsessive-Compulsive Disorder (OCD). However, it is associated with several side effects, including urinary retention. This case report discusses the case of a 20-year-old male with OCD who developed urinary retention following clomipramine administration.

Case Representation

A 20-year-old male with a one-year history of OCD with psychotic features was admitted to SIR-T Hospital, Bhavnagar, due to worsening symptoms. He was prescribed clomipramine along with other psychotropic medications. On the 16th day of hospitalization, the patient experienced acute urinary retention, necessitating catheterization. Clomipramine dosage was subsequently reduced, resulting in the resolution of urinary retention. The patient was discharged after 29 days with no further urinary complications.

Discussion

The causality assessment suggested a probable link between clomipramine and urinary retention, supported by the Naranjo Scale, WHO-UMC criteria, and literature. The anticholinergic properties of clomipramine likely contributed to the condition. Despite its side effects, clomipramine remains a valuable treatment for OCD, requiring careful dose management to mitigate adverse effects.

Conclusion

Clinicians should be vigilant for urinary retention in patients receiving clomipramine, especially at higher doses. Regular monitoring and dose adjustments are crucial for managing this side effect without compromising the therapeutic benefits for OCD.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863337946250101110356
2025-01-28
2025-09-12

  • From This Site

    /content/journals/cds/10.2174/0115748863337946250101110356
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MartinJ. Investigating chronic urinary retention.BMJ201934717951797
     [Google Scholar]
  2. DoughertyJM. Male urinary retention.StatPearlsStatPearls PublishingTreasure Island (FL)2020
     [Google Scholar]
  3. GhosseinN. Anticholinergic medications.StatPearlsStatPearls PublishingTreasure Island (FL)2023
     [Google Scholar]
  4. VerhammeK.M.C. SturkenboomM.C.J.M. StrickerB.H.C. BoschR. Drug-induced urinary retention: Incidence, management and prevention.Drug Saf.200831537338810.2165/00002018‑200831050‑0000218422378
     [Google Scholar]
  5. WexlerP. Tricyclic antidepressants.ScienceDirect.OxfordAcademic Press2014838845
     [Google Scholar]
  6. WilsonM. Clomipramine.StatPearlsStatPearls PublishingTreasure Island (FL)2020
     [Google Scholar]
  7. NaranjoC.A. BustoU. SellersE.M. SandorP. RuizI. RobertsE.A. JanecekE. DomecqC. GreenblattD.J. A method for estimating the probability of adverse drug reactions.Clin. Pharmacol. Ther.198130223924510.1038/clpt.1981.1547249508
     [Google Scholar]
  8. The use of the WHO-UMC system for standardized case causality assessment.2024Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf
  9. HartwigSC. Preventability and severity assessment in reporting adverse drug reactions.Am J Health-Syst Pharm.199249922292232
     [Google Scholar]
  10. SchumockGT. Focusing on the preventability of adverse drug reactions.Hosp Pharm.1992Jun276538
     [Google Scholar]
  11. Medication safety in polypharmacy.2019Available from: https://www.who.int/docs/default-source/patient-safety/who-uhc-sds-2019-11-eng.pdf
  12. GardnerDM. Antipsychotic side effects and monitoring implications.Cambridge University PressCambridge2019
     [Google Scholar]
  13. PigottT.A. PatoM.T. BernsteinS.E. GroverG.N. HillJ.L. TolliverT.J. MurphyD.L. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.Arch. Gen. Psychiatry1990471092693210.1001/archpsyc.1990.018102200420052222131
     [Google Scholar]
/content/journals/cds/10.2174/0115748863337946250101110356
Loading
Clomipramine-Induced Urinary Retention in an Adult Male - A Case Report
Curr Drug Saf 20, 501 (2025); https://doi.org/10.2174/0115748863337946250101110356
/content/journals/cds/10.2174/0115748863337946250101110356
/content/journals/cds/10.2174/0115748863337946250101110356
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): anticholinergic; case report; Clomipramine; obsessive-compulsive disorder; tricyclic antidepressant; urinary retention

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test